Akoya Biosciences Announces Pricing of Public Offering of Common Stock
08 juin 2023 00h55 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its public offering of 8,700,000...
Akoya Biosciences Announces Public Offering of Common Stock
07 juin 2023 16h08 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has launched an underwritten public offering...
Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
08 mai 2023 16h05 HE
|
Akoya Biosciences, Inc.
Q1 2023 revenue $21.4 million, 27% y/y growth Reiterating FY 2023 revenue guidance range of $95-98 million MARLBOROUGH, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq:...
Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
27 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has shipped it’s 1,000th instrument, a...
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
12 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
Enable Cloud Platform trained on high plex spatial imaging datasets across 20,000 samples run on the PhenoCycler® SystemCommercial launch at AACR 2023 Annual Meeting (Akoya booth #1713) ...
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
12 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion systemFirst protein panel commercially available at AACR 2023 Annual Meeting and first RNA panel...
Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023
06 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
Akoya Biosciences Announces Leadership Transition
20 mars 2023 16h00 HE
|
Akoya Biosciences, Inc.
Joe Driscoll to Retire After More than Four Successful Years as Chief Financial Officer Johnny Ek Appointed as new Chief Financial Officer MARLBOROUGH, Mass., March 20, 2023 (GLOBE NEWSWIRE) --...
Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance
06 mars 2023 16h05 HE
|
Akoya Biosciences, Inc.
Q4 2022 revenue $21.2 million and FY 2022 revenue $74.9 millionFY 2023 revenue guidance range $95-98 million MARLBOROUGH, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc....
Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel
28 févr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Jennifer Kamocsay as General...